Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Faydra I, Lieveld"'
1
Akademický článek
Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection
Autor: Faydra I. Lieveld, Niels Swaans, Astrid M. Newsum, Cynthia K.Y. Ho, Janke Schinkel, Richard Molenkamp, Jan T.M. van der Meer, Joop E. Arends, Andy I.M. Hoepelman, Anne M.J. Wensing, Peter D. Siersema, Karel J. van Erpecum, Greet J. Boland
Publikováno v: Annals of Hepatology, Vol 15, Iss 5, Pp 696-704 (2016)
Background and aim. Resistance-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but data in human immunodeficiency virus (HIV) coinfected patients are scarce. We assessed frequencies o
Externí odkaz: https://doaj.org/article/ef7f7c7b6ddf4c0f9a907447d000c29e
Zobrazit plný text záznamu
2
Akademický článek
Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review
Autor: Faydra I. Lieveld, Lotte G. van Vlerken, Peter D. Siersema, Karel J van Erpecum
Publikováno v: Annals of Hepatology, Vol 12, Iss 3, Pp 380-391 (2013)
Introduction. Poor adherence to treatment for various chronic diseases is a frequent phenomenon. Current guidelines for the treatment of chronic hepatitis B (HBV) and hepatitis C (HCV) recommend optimal adherence, since it has been suggested that poo
Externí odkaz: https://doaj.org/article/5c13b54b626742c9bf6c308d2cfcb975
Zobrazit plný text záznamu
3
Decreased All-cause and liver-related mortality risk in HIV/Hepatitis B virus coinfection coinciding with the introduction of tenofovir-containing combination antiretroviral therapy
Autor: Joop E. Arends, Berend J van Welzen, Anders Boyd, Annemarie E. Brouwer, Peter Reiss, Andy I.M. Hoepelman, Colette Smit, Faydra I Lieveld, Tania Mudrikova
Publikováno v: Open Forum Infectious Diseases
Open forum infectious diseases, 7(7):ofaa226. Oxford University Press
Background The development of efficacious combination antiretroviral therapy (cART) has led to a dramatic decrease in mortality in HIV-positive patients. Specific data on the impact in HIV/hepatitis B virus (HBV)–coinfected patients are lacking. In
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8682c97bcb039b6ff8ea6444445252f8
https://doi.org/10.1093/ofid/ofaa226
Zobrazit plný text záznamu
4
New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review
Autor: Shazaad Ahmad, Joop E. Arends, Andrew Ustianowski, Faydra I. Lieveld
Publikováno v: Infectious Diseases and Therapy
Although current therapies can be successful at suppressing hepatitis B viral load, long-term viral cure is not within reach. Subsequent strategies combining pegylated interferon alfa with nucleoside/nucleotide analogues have not resulted in any majo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a264471590ffc351b37aa9682b478c12
http://europepmc.org/articles/PMC5700893
Zobrazit plný text záznamu
5
The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study
Autor: Faydra I. Lieveld, Linde Amelung, Patricia A. M. Kracht, Karel J. van Erpecum, Joop E. Arends, Andy I. M. Hoepelman, Carina J.R. Verstraete, Eveline P. Mauser-Bunschoten, Joep de Bruijne, Peter D. Siersema
Publikováno v: Infectious Diseases and Therapy
Infectious Diseases and Therapy, 7, 3, pp. 373-385
Infectious Diseases and Therapy, 7(3), 373. Springer Healthcare
Infectious Diseases and Therapy, 7, 373-385
Introduction: Pegylated interferon-based therapy for hepatitis C virus (HCV) negatively impacts nutritional state and patient-reported outcomes (PROs) such as health-related quality of life (HRQL). Clinical trials with direct-acting antivirals (DAAs)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b8ec09434d5531fa7bd26388ee9e21
https://pubmed.ncbi.nlm.nih.gov/30076582
Zobrazit plný text záznamu
6
Real life adherence of chronic hepatitis B patients to entecavir treatment
Autor: Harry L.A. Janssen, Willem P. Brouwer, Peter D. Siersema, Karel J. van Erpecum, Joop E. Arends, Faydra I. Lieveld, Pauline Arends, Lotte G. van Vlerken
Publikováno v: Digestive and Liver Disease, 47, 7, pp. 577-83
Digestive and liver disease, 47(7), 577. Elsevier
Digestive and Liver Disease, 47(7), 577-583. Elsevier
Digestive and Liver Disease, 47, 577-83
Background: Real-life prospective data on adherence to nucleos( t)ide analogues in chronic hepatitis B patients are scarce. Aims: We investigated adherence to entecavir in relation to virological response. Methods: In this prospective study, we provi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3446cf5ef64d79f99df0721f11111b00
https://pure.eur.nl/en/publications/22b338ee-69af-4c60-9c5d-82124d2c9104
Zobrazit plný text záznamu
7
Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease
Autor: Carel-Peter van Erpecum, Joop E. Arends, Faydra I. Lieveld, Maria Cristina Leoni, Linde Amelung, Joep de Bruijne, Janneke van den Brink, Karel J. van Erpecum
Publikováno v: Clinics and research in hepatology and gastroenterology, 43(1), 37-44
Clinics and Research in Hepatology and Gastroenterology, 43(1), 37. Elsevier Masson
BACKGROUND:Ursodeoxycholic acid (UDCA) is used for treatment of cholestatic liver diseases and may improve long-term outcome. Although treatment with this hydrophilic bile acid is virtually without side effects, medication adherence might be suboptim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f34e30d4c74facfc2eae02124145cb0
https://doi.org/10.1016/j.clinre.2018.08.006
Zobrazit plný text záznamu
8
Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review
Autor: Lotte G. van Vlerken, Faydra I. Lieveld, Peter D. Siersema, Karel J. van Erpecum
Publikováno v: Annals of Hepatology, Vol 12, Iss 3, Pp 380-391 (2013)
Introduction. Poor adherence to treatment for various chronic diseases is a frequent phenomenon. Current guidelines for the treatment of chronic hepatitis B (HBV) and hepatitis C (HCV) recommend optimal adherence, since it has been suggested that poo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d919b87b99ea195392e39ecf8b45b5aa
http://www.sciencedirect.com/science/article/pii/S1665268119310002
Zobrazit plný text záznamu
10
Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment: Results from a randomized controlled trial using real-time medication monitoring
Autor: Lotte G. van Vlerken, Karin M.J. van Nieuwkerk, Karel J. van Erpecum, Pieter Friederich, Peter D. Siersema, Ger H. Koek, Faydra I. Lieveld, Joop E. Arends, David M. Burger, Suzanne van Meer
Publikováno v: Clinics and Research in Hepatology and Gastroenterology, 40, 622-630
Clinics and Research in Hepatology and Gastroenterology, 40(5), 622. Elsevier Masson
Clinics and Research in Hepatology and Gastroenterology, 40, 5, pp. 622-630
van Vlerken, L G, Lieveld, F I, van Nieuwkerk, CMJ, van Meer, S, Koek, G H, Friederich, P, Arends, J E, Siersema, P D, Burger, D M & van Erpecum, K J 2016, ' Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment : Results from a randomized controlled trial using real-time medication monitoring ', Clinics and research in hepatology and gastroenterology, vol. 40, no. 5, pp. 622-630 . https://doi.org/10.1016/j.clinre.2015.12.014
Clinics and research in hepatology and gastroenterology, 40(5), 622-630. Elsevier Masson
Item does not contain fulltext BACKGROUND AND OBJECTIVE: Adherence is essential in antiviral therapy for chronic hepatitis C. We investigated the effect of real-time medication monitoring on adherence to ribavirin. METHODS: In this randomized control
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0151006fedec5a44d4269fb9e6e6487
https://doi.org/10.1016/j.clinre.2015.12.014
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje